Maeve Xavier

Maeve Xavier supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that sustain the agency’s regulatory science infrastructure. She manages a diverse portfolio of acquisitions focused on scientific research support, laboratory operations, and specialized analytical instrumentation essential for drug safety and medical device evaluation. Her work directly enables the FDA’s public health mandate by ensuring timely access to high-precision technical services and mission-enabling facilities. She routinely handles complex contract actions under FAR Part 16, including cost-reimbursement, time-and-materials, and indefinite-delivery/indefinite-quantity instruments tailored to scientific and technical service requirements. Xavier maintains consistent working relationships with niche scientific service providers, including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc, and Progenics Pharmaceuticals Inc, reflecting a preference for specialized vendors with domain expertise in preclinical research, toxicology, and pharmaceutical development. Her contracting patterns emphasize long-term, performance-based partnerships with firms possessing deep technical proficiency in regulatory-compliant laboratory operations and data-driven research support, rather than broad commercial vendors. These relationships are built on demonstrated capability in meeting FDA’s stringent quality and compliance standards. Her procurement approach prioritizes open competition, with approximately 70% of awards issued without set-aside designations, while still maintaining active engagement with small business programs. She regularly utilizes Total Small Business Set-Asides and 8(a) competed contracts, demonstrating a balanced commitment to socioeconomic objectives without compromising technical rigor. Her contracting decisions reflect a deliberate alignment with agency priorities to foster innovation while ensuring vendor reliability and regulatory alignment. Xavier’s primary procurement focus lies in NAICS 541715 (research and development in life sciences), 541513 (computer facilities management), and 518210 (data infrastructure services), underscoring her specialization in supporting modern scientific computing environments, data processing systems, and laboratory automation platforms. Her expertise centers on procuring technical services that underpin the FDA’s ability to conduct cutting-edge regulatory science in support of public health.